Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yunhe Qin"'
Autor:
Xiang Li, Jiuliang Zhao, Mengtao Li, Guanqiao Li, Jiachen Xu, Bing Xu, Yangzhong Zhou, Yunhe Qin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Phase III clinical trials are pivotal for evaluating therapeutics, yet a concerning failure rate has been documented, particularly impacting oncology where accelerated approvals of immunotherapies are common. These failures are predominant
Externí odkaz:
https://doaj.org/article/525569cbd2394e49975deaa69f1027a8
Autor:
Yang Liu, Ning Zhang, Cuicui Xie, Yale Jiang, Yunhe Qin, Liyun Zhou, Yi Fan, Lianjie Ren, Chen Yin, Huan Yang, Wei Xie, Qing Zhai, Guanqiao Li, Hongzhuan Chen, Xiaoyuan Chen
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 12, Pp 4365-4377 (2022)
Over the past two decades, China has introduced significant changes to drug regulations through regulatory innovations to accelerate drug review and approvals, keeping in line with the rapidly growing scientific innovation in drug research and develo
Externí odkaz:
https://doaj.org/article/9c37d93359984c7c9a8142c123ecd2e0
Publikováno v:
Nature reviews. Drug discovery. 20(1)
Publikováno v:
Nature Reviews Drug Discovery. 21:484-484